Flarex en es it fr

Flarex Brand names, Flarex Analogs

Flarex Brand Names Mixture

  • L-S 100 Soluble Powder (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Sulfate))
  • Lincomycin Spectinomycin 100 Soluble Powder (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Hydrochloride))
  • Lincomycin Spectinomycin 4.4% G Premix (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Hydrochloride))

Flarex Chemical_Formula


Flarex RX_link


Flarex fda sheet

Flarex FDA

Flarex msds (material safety sheet)

Flarex MSDS

Flarex Synthesis Reference

No information avaliable

Flarex Molecular Weight

376.462 g/mol

Flarex Melting Point

297 oC

Flarex H2O Solubility

30 mg/L

Flarex State


Flarex LogP


Flarex Dosage Forms

Drops; Suspension

Flarex Indication

A topical anti-inflammatory product for ophthalmic use. For the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe

Flarex Pharmacology

No information avaliable

Flarex Absorption

No information avaliable

Flarex side effects and Toxicity

Side effects may include acute anterior uveitis and perforation of the globe. Keratitis, conjunctivitis, corneal ulcers, mydriasis, conjunctival hyperemia, loss of accommodation and ptosis have occasionally been reported following local use of corticosteroids. LD50 = 234 mg/kg (rats)

Flarex Patient Information

Flarex Organisms Affected

Humans and other mammals